• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Mupadolimab Antibody – Human

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818661

Mupadolimab (CPI-006) is a humanized FC-gammaR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Mupadolimab, Antibody
Full Product Name
Mupadolimab
Product Synonym Names
CPI-006
Host
Human
Species Reactivity
CD73
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
2451856-97-4
In_vitro
Mupadolimab (10 mg/kg; intraperitoneal injection; once daily for 15 days) stimulates antigen-specific humoral immunity in NSG-SGM3 mice infected with SARS-CoV-2[1].

Other Notes

Small volumes of anti-Mupadolimab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Mupadolimab purchase

MBS5818661 is an antibody targeting Mupadolimab. Reactive in CD73. Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000